| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/14/1995 | US5389655 Treats angina pectoris |
| 02/14/1995 | US5389653 Inhibitors of the enzyme catechol-O-methyltransferase; useful as co-medication in treatment of Parkinson's disease |
| 02/14/1995 | US5389652 3-cycloalkyl-prop-2-enamides |
| 02/14/1995 | US5389650 Antiinflammatory agents, anticoagulants, antispasmodic agents |
| 02/14/1995 | US5389649 Relax vascular smooth muscle |
| 02/14/1995 | US5389647 Renin inhibitors |
| 02/14/1995 | US5389646 For controlling bone metabolism |
| 02/14/1995 | US5389644 For increasing sensitivity of tumor cells to antitumor agents without side effects |
| 02/14/1995 | US5389643 Aminobenzoic acid derivatives useful for treating gastro-intestinal conditions |
| 02/14/1995 | US5389642 Exhibit antagonistic properties toward angiotensin(II); useful for treatment of hypertensioni, aldosteronism, cardiac insufficiency, increased intraocular pressure and disorders of the central nervous system |
| 02/14/1995 | US5389639 Amino alkanoic esters of rapamycin |
| 02/14/1995 | US5389634 Imidazole derivatives having angiotensin II receptor antagonistic activity |
| 02/14/1995 | US5389633 Triazolopyridazine compounds, their production and use |
| 02/14/1995 | US5389631 Fibrinogen receptor antagonists |
| 02/14/1995 | US5389630 Diamine compound and brain protecting agent containing the same |
| 02/14/1995 | US5389626 3-aryloxmethyl-cephalosporin derivatives, and their medical use |
| 02/14/1995 | US5389625 Sweet taste; oral administering |
| 02/14/1995 | US5389624 Antiandrogenic [3,2-c]pyrazole and [3,2-d]triazole steroids |
| 02/14/1995 | US5389621 Method of enhancing the anticoagulant effects of aspirin using salicylamide |
| 02/14/1995 | US5389618 Having bioavailability and antithrombotic activity greater than heparin |
| 02/14/1995 | US5389617 To reduce side effects by administering azauridine compound in low dosage levels during initial period followed by administering at elevated levels |
| 02/14/1995 | US5389614 Anticoagulants |
| 02/14/1995 | US5389610 Carboxyalkylcarbonyl aminoacid endopeptidase inhibitors |
| 02/14/1995 | US5389530 Methods for the production of antibodies and induction of immune responses to tumor-associated ganagliosides by immunization with gangloiside lactones |
| 02/14/1995 | US5389521 Carbohydrate receptor for bacteria and method for use thereof |
| 02/14/1995 | US5389383 Method for treating hypoxia-associated ocular complications |
| 02/14/1995 | US5389378 Benzoporphyrin vesicles and their use in photodynamic therapy |
| 02/14/1995 | US5389375 Stable suppository formulations effecting bioavailability of Δ9 -thc |
| 02/14/1995 | US5389373 Preparation of oil-in-water emulsions of drugs |
| 02/14/1995 | US5389372 Addition of sucrose extends shelf life |
| 02/14/1995 | US5389370 Active component concentrates and new active component combinations from ginkgo biloba leaves, their method of preparation and pharmaceuticals containing the active component concentrates or the active component combinations |
| 02/14/1995 | US5389369 Halo peroxidase containing compositions for killing yeast and sporular microorganisms |
| 02/14/1995 | US5389360 Oral compositions |
| 02/14/1995 | US5389359 Pharmaceutical preparation containing L-aspartate or L-asparagine for preventing ethanol toxicity, and process for preparation thereof |
| 02/14/1995 | CA2130020A1 Sulphonylbenzyl-substituted benzimidazoles, a process for their preparation and their use in medicaments |
| 02/14/1995 | CA2129704A1 Pharmaceutical compounds |
| 02/14/1995 | CA2129692A1 Pharmaceutical compounds |
| 02/14/1995 | CA1334470C Antithrombogenic and antibiotic compositions and methods of preparation thereof |
| 02/14/1995 | CA1334467C Fine-beaded colestipol hydrochloride |
| 02/14/1995 | CA1334424C Thiochroman esters of phenols and terephthallates having retinoid-like activity |
| 02/14/1995 | CA1334416C 4-phenyl-4-¬n-(phenyl)amido|piperidine derivatives and pharmaceutical compositions and method employing such compounds |
| 02/14/1995 | CA1334414C Discorhabdin compositions and their methods of use |
| 02/14/1995 | CA1334413C Amino-substituted bridged azabicyclic quinolone carboxylic acids and esters |
| 02/14/1995 | CA1334409C Diphosphonic acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them |
| 02/14/1995 | CA1334408C Dithiolane derivatives |
| 02/14/1995 | CA1334407C Method for the preparation of novel alcoyloxime derivatives of 7-amino-thiazolyl-acetamido-cephalosporanic acid |
| 02/14/1995 | CA1334392C Immunosuppressant agent |
| 02/14/1995 | CA1334391C Immunosuppressant compound |
| 02/14/1995 | CA1334384C Supression of pneumocystis carinii using aerosolized pentamidine treatment |
| 02/14/1995 | CA1334383C Method for treating autoimmune disease using succinylacetone |
| 02/14/1995 | CA1334382C Osmotic continuous dispensing oral delivery system containing a pharmaceutically acceptable active agent having improved core membrane adhesion properties |
| 02/14/1995 | CA1334381C Treatment of asthma with inhaled furosemide |
| 02/14/1995 | CA1334380C Antiarteriosclerotic agent |
| 02/14/1995 | CA1334379C Method for preparing a solid sustained release form of a functionally active composition |
| 02/12/1995 | CA2129701A1 Medicaments containing 1-thiocarbamoyl-5-hydroxy-pyrazoles and their use as agents for combating septic shock |
| 02/12/1995 | CA2128641A1 Stabilized solutions of platinum (ii) antitumor agents |
| 02/10/1995 | CA2129689A1 Identification and use of protease inhibitors |
| 02/10/1995 | CA2128557A1 Oxime derivatives of cephalosporanic structure and compounds for their preparation |
| 02/09/1995 | WO1995004277A1 A method for preparing and selecting pharmaceutically useful non-peptide compounds from a structurally diverse universal library |
| 02/09/1995 | WO1995004142A2 Antisense oligonucleotide inhibition of vascular endothelial growth factor expression |
| 02/09/1995 | WO1995004135A1 Fungicidal methods and compositions for killing yeast and sporular microorganisms |
| 02/09/1995 | WO1995004070A1 15,15-dialkyl-substituted derivatives of estradiol |
| 02/09/1995 | WO1995004065A1 Processes and intermediates for phosphorous-containing covalent linkages |
| 02/09/1995 | WO1995004061A1 Activated macrolactams having immunomodulatory activities |
| 02/09/1995 | WO1995004060A1 Rapamycin derivative with antimicrobial, anticancer and immunomodulation activity |
| 02/09/1995 | WO1995004059A1 Novel benzothiophene analogs as antiviral agents |
| 02/09/1995 | WO1995004058A1 2-(3-benzoylphenyl)propionic acid codeine salt, preparation method therefor and pharmaceutical compositions containing said salt |
| 02/09/1995 | WO1995004057A1 TRICYCLIC INHIBITORS OF THE GPIIbIIIa RECEPTOR |
| 02/09/1995 | WO1995004056A1 Heterocyclic amines having central nervous system activity |
| 02/09/1995 | WO1995004055A1 Thiazole derivatives as lipoxygenase inhibitors |
| 02/09/1995 | WO1995004053A1 Urea and thiourea derivatives and process for their preparation |
| 02/09/1995 | WO1995004052A1 Methylguanidine derivatives, methods for preparing same and compositions containing said derivatives |
| 02/09/1995 | WO1995004051A1 Piperazine compounds used in therapy |
| 02/09/1995 | WO1995004049A1 PIPERAZINE DERIVATIVES AS α1A-ADRENERGIC RECEPTOR ANTAGONISTS |
| 02/09/1995 | WO1995004048A1 Benzoxazinones and benzothiazinones endowed with therapeutic activity |
| 02/09/1995 | WO1995004047A1 2-benzoheterocyclyloxy or thiopropanolamine derivatives with adreno receptor agonist activity |
| 02/09/1995 | WO1995004045A1 Compounds as pde iv and tnf inhibitors |
| 02/09/1995 | WO1995004042A1 4-phenyl-4-phenylpropyl(enyl)-piperidines as tachykinin antagonists |
| 02/09/1995 | WO1995004040A1 Perhydroisoindole derivatives as p substance antagonists |
| 02/09/1995 | WO1995004039A1 2-phenylpyrrole derivatives as dopamine d3 receptor antagonists |
| 02/09/1995 | WO1995004037A1 2-(2-hydroxyphenyl)-5-(n-phenylmethyl-aminomethyl)-pyrroles as antipsychotic agents |
| 02/09/1995 | WO1995004036A1 Compounds having selective activity for retinoid x receptors, and means for modulation of processes mediated by retinoid x receptors |
| 02/09/1995 | WO1995004034A1 (thio)carbimidinic acid derivatives and medicaments containing the same |
| 02/09/1995 | WO1995004033A1 Succinamide derivatives, processes for their preparation and their use as gelatinase and collagenase inhibitors |
| 02/09/1995 | WO1995004030A1 Therapeutic compound - fatty acid conjugates |
| 02/09/1995 | WO1995004028A1 Indane and tetrahydronaphthalene derivatives as calcium channel antagonists |
| 02/09/1995 | WO1995004027A1 Aminoindanes and related compounds useful as calcium-channel antagonists |
| 02/09/1995 | WO1995003832A1 Intracellular immunization |
| 02/09/1995 | WO1995003830A2 Prodrugs of farnesyl transferase inhibitors for adept or vdept |
| 02/09/1995 | WO1995003827A1 Method for treating multiple sclerosis |
| 02/09/1995 | WO1995003811A1 Therapeutic skin composition |
| 02/09/1995 | WO1995003810A1 Use of esculentoside a for treatment of lipopolysaccharide and macrophage mediated disorders |
| 02/09/1995 | WO1995003809A2 Use of glucokinase inhibitors for the manufacture of a medicament for treating tumours |
| 02/09/1995 | WO1995003808A1 Antiacid pharmaceutical composition in the form of a suspension based on sucralphate gel |
| 02/09/1995 | WO1995003807A1 Treatment of age-related macular degeneration |
| 02/09/1995 | WO1995003806A1 Remedy for parkinson's disease |
| 02/09/1995 | WO1995003805A1 Stabilized formulation |
| 02/09/1995 | WO1995003804A1 Methods of enhancing opiate analgesic potency or detoxifying an opiate addict |
| 02/09/1995 | WO1995003803A1 SUBSTITUTED FURO[3',4':6,7]INDOLIZINO[1,2-b]QUINOLINONES |
| 02/09/1995 | WO1995003802A1 Aqueous composition |